Inactive

Amendment 2 The purpose of this amendment is to: correct the reference in Research Area of Interest 7.3.2. Please see attached document entitled FDABAA-20-00123 - Amendment 2 for the most current vers... Amendment 2 The purpose of this amendment is to: correct the reference in Research Area of Interest 7.3.2. Please see attached document entitled FDABAA-20-00123 - Amendment 2 for the most current version of the FDA's Broad Agency Announcement. The White Paper due date remains unchanged at March 2, 2020, 5:00pm EST. Amendment 1 The purpose of this amendment is to: provide the FDA's updated research areas of interest; provide additional information regarding proposal instructions; and, change the White Paper due date from March 13, 2020, to March 2, 2020. Please see the attached document entitled FDABAA-20-00123 - Amendment 1 for the most current version of the FDA's Broad Agency Announcement. Original Description The Food and Drug Administration (FDA) solicits for advanced research and development proposals to support regulatory science and innovation. The FDA anticipates that research and development activities under this Broad Agency Announcement (BAA) will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation. *This announcement is a renewal of the FY19 announcement (FDABAA-19-00123) and will remain open until further notice. It is renewed on an annual basis.